{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:27:27Z","timestamp":1790515647564,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccine-induced thrombotic thrombocytopenia with cerebral venous thrombosis is a syndrome recently described in young adults within two weeks from the first dose of the ChAdOx1 nCoV-19 vaccine. Here we report two cases of malignant middle cerebral artery (MCA) infarct and thrombocytopenia 9-10 days following ChAdOx1 nCoV-19 vaccination. The two cases arrived in our facility around the same time but from different geographical areas, potentially excluding epidemiological links; meanwhile, no abnormality was found in the respective vaccine batches. Patient 1 was a 57-year-old woman who underwent decompressive craniectomy despite two prior, successful mechanical thrombectomies. Patient 2 was a 55-year-old woman who developed a fatal bilateral malignant MCA infarct. Both patients manifested pulmonary and portal vein thrombosis and high level of antibodies to platelet factor 4-polyanion complexes. None of the patients had ever received heparin in the past before stroke onset. Our observations of rare arterial thrombosis may contribute to assessment of possible adverse effects associated with COVID-19 vaccination.<\/jats:p>","DOI":"10.1038\/s41467-021-25010-x","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T06:04:43Z","timestamp":1627884283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-4309","authenticated-orcid":false,"given":"M.","family":"De Michele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-3278","authenticated-orcid":false,"given":"M.","family":"Iacobucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-1376","authenticated-orcid":false,"given":"A.","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-6327","authenticated-orcid":false,"given":"E.","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pulcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cerbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Merenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. G.","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Berto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Caracciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Truglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"25010_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"25010_CR2","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher, A. et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N. Engl. J. Med. 384, 2092\u20132101 (2021).","journal-title":"N. Engl. J. Med"},{"key":"25010_CR3","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz, N. H. et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 384, 2124\u20132130 (2021).","journal-title":"N. Engl. J. Med."},{"key":"25010_CR4","doi-asserted-by":"publisher","unstructured":"Scully, M. et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2105385 (2021).","DOI":"10.1056\/NEJMoa2105385"},{"key":"25010_CR5","doi-asserted-by":"publisher","unstructured":"Blauenfeldt, R. A. et al. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J. Thromb. Haemost. https:\/\/doi.org\/10.1111\/jth.15347 (2021).","DOI":"10.1111\/jth.15347"},{"key":"25010_CR6","doi-asserted-by":"publisher","unstructured":"Al-Mayhani, T. et al. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2021-326984 (2021).","DOI":"10.1136\/jnnp-2021-326984"},{"key":"25010_CR7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMc2105869","volume":"384","author":"KL Muir","year":"2021","unstructured":"Muir, K. L., Kallam, A., Koepsell, S. A. & Gundabolu, K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N. Engl. J. Med. 384, 1964\u20131965 (2021).","journal-title":"N. Engl. J. Med."},{"key":"25010_CR8","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMc2106075","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff, J., Davis, K. & Douoguih, M. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination\u2014response from the manufacturer. N. Engl. J. Med. 384, 1965\u20131966 (2021).","journal-title":"N. Engl. J. Med."},{"key":"25010_CR9","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2021.7517","volume":"325","author":"I See","year":"2021","unstructured":"See, I. et al. US Case Reports of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Ad26.COV2.S Vaccination March 2 to April 21 2021. JAMA 325, 2448\u20132456 (2021).","journal-title":"JAMA"},{"key":"25010_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","volume":"53","author":"W Hacke","year":"1996","unstructured":"Hacke, W. et al. \u2018Malignant\u2019 middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol. 53, 309\u2013315 (1996).","journal-title":"Arch. Neurol."},{"key":"25010_CR11","doi-asserted-by":"publisher","first-page":"n1114","DOI":"10.1136\/bmj.n1114","volume":"373","author":"A Potteg\u00e5rd","year":"2021","unstructured":"Potteg\u00e5rd, A. et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 373, n1114 (2021).","journal-title":"BMJ"},{"key":"25010_CR12","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood.2020005157","volume":"135","author":"TE Warkentin","year":"2020","unstructured":"Warkentin, T. E. HIT: still stringing us along. Blood 135, 1193\u20131194 (2020).","journal-title":"Blood"},{"key":"25010_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1182\/blood.2018881607","volume":"135","author":"I Johnston","year":"2020","unstructured":"Johnston, I. et al. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation. Blood 135, 1270\u20131280 (2020).","journal-title":"Blood"},{"key":"25010_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3324\/haematol.2019.219881","volume":"105","author":"S Staessens","year":"2020","unstructured":"Staessens, S. et al. Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica 105, 498\u2013507 (2020).","journal-title":"Haematologica"},{"key":"25010_CR15","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","volume":"98","author":"MP Reilly","year":"2001","unstructured":"Reilly, M. P. et al. Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA. Blood 98, 2442\u20132447 (2001).","journal-title":"Blood"},{"key":"25010_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archsurg.1979.01370280026004","volume":"114","author":"JB Towne","year":"1979","unstructured":"Towne, J. B., Bernhard, V. M., Hussey, C. & Garancis, J. C. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch. Surg. 114, 372\u2013377 (1979).","journal-title":"Arch. Surg."},{"key":"25010_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1177\/0271678X19856131","volume":"39","author":"M Bacigaluppi","year":"2019","unstructured":"Bacigaluppi, M., Semerano, A., Gullotta, G. S. & Strambo, D. Insights from thrombi retrieved in stroke due to large vessel occlusion. J. Cereb. Blood Flow Metab. 39, 1433\u20131451 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"25010_CR18","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/jth.13813","volume":"15","author":"A Greinacher","year":"2017","unstructured":"Greinacher, A., Selleng, K. & Warkentin, T. E. Autoimmune heparin-induced thrombocytopenia. J. Thromb. Haemost. 15, 2099\u20132114 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"25010_CR19","doi-asserted-by":"publisher","unstructured":"Z\u0105bczyk, M., Natorska, J. & Undas, A. Factor XIII and fibrin clot properties in acute venous thromboembolism. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22041607 (2021).","DOI":"10.3390\/ijms22041607"},{"key":"25010_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","volume":"12","author":"TE Warkentin","year":"2019","unstructured":"Warkentin, T. E. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev. Hematol. 12, 685\u2013698 (2019).","journal-title":"Expert Rev. Hematol."},{"key":"25010_CR21","doi-asserted-by":"publisher","unstructured":"Thaler, J. et al. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J. Thromb. Haemost. https:\/\/doi.org\/10.1111\/jth.15346 (2021).","DOI":"10.1111\/jth.15346"},{"key":"25010_CR22","doi-asserted-by":"crossref","unstructured":"Graf, T. et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J. Neurol. 1\u20133 (2021).","DOI":"10.1007\/s00415-021-10599-2"},{"key":"25010_CR23","doi-asserted-by":"publisher","first-page":"e010133","DOI":"10.1161\/JAHA.118.010133","volume":"7","author":"M Paciaroni","year":"2018","unstructured":"Paciaroni, M. et al. Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes. J. Am. Heart Assoc. 7, e010133 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"25010_CR24","doi-asserted-by":"publisher","unstructured":"Cines, D. B. & Bussel, J. B. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMe2106315 (2021).","DOI":"10.1056\/NEJMe2106315"},{"key":"25010_CR25","doi-asserted-by":"publisher","unstructured":"Greinacher, A. et al. Towards understanding ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-440461\/v1 (2021).","DOI":"10.21203\/rs.3.rs-440461\/v1"},{"key":"25010_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.thromres.2021.05.010","volume":"203","author":"J Douxfils","year":"2021","unstructured":"Douxfils, J. et al. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb. Res. 203, 163\u2013171 (2021).","journal-title":"Thromb. Res."},{"key":"25010_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"25010_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1080\/09537104.2017.1293803","volume":"28","author":"ML Guarino","year":"2017","unstructured":"Guarino, M. L. et al. New platelet functional method for identification of pathogenic antibodies in HIT patients. Platelets 28, 728\u2013730 (2017).","journal-title":"Platelets"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25010-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:40:41Z","timestamp":1669970441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25010-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25010"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25010-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-448338\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"8 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4663"}}